“VAGABOND Validation of Actionable Genomic ABerrations in a paediatric Oncology Network for Doctorate students” aims to create a multidisciplinary and multi-sectoral program to validate new therapeutic interventions in paediatric cancer. The program is funded by the European Commission under the Horizon 2020 programme (Marie Sklodowska-Curie Actions Innovative Training Network) and offers 15 fully funded PhD positions. The consortium is coordinated by the Princess Máxima Center for Pediatric Oncology and consists of 12 academic and 6 non-academic partners from 8 European countries.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 956285
Company Details
- Employees
- 4
- Address
- Utrecht, Nl
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://www.vagabondnetwork.com
- HQ
- Utrecht
Vagabond Itn Network Questions
Vagabond Itn Network's website is http://www.vagabondnetwork.com
Vagabond Itn Network's LinkedIn profile is https://nl.linkedin.com/company/vagabond-itn-network
Vagabond Itn Network has
4 employees.
View email and phone details for 4
employees at Vagabond Itn Network.
Vagabond Itn Network's industry is
Research Services
Vagabond Itn Network's top competitors are
Leader Biomedical,
Ms Reinsurance,
Elevate,
Pno Innovation Europe,
Amolf,
Tno,
Jelle | Method21,
Amcor Flexibles Italia Srl,
Bsl Media & Learning,
Etudes Sans Frontières – Studieren Ohne Grenzen Deutschland E.v..
Vagabond Itn Network's categories are Research Services
